Kinase Inhibitor Discovery
with an untiring quest for future therapeutics

Publication in Journal of Medicinal Chemistry Describing the Discovery of BTK Inhibitor AS-1763

FY2021 Q2 Presentation

Consolidated Financial Results for the Second Quarter of the Year Ending December 31, 2021

Carna Announces Completion of Dosing in Phase 1 SAD Study of AS-1763

Corporate Presentation July 2021

Carna Announces Positive Results for AS-0871 Phase 1 Single Ascending Dose Clinical Trial

Carna Announces Dosing of the First Patient in a First-in-Human Phase 1 Study of AS-0141

Financial Results FY2021Q1